Functions of the HIV-1 matrix protein p17

New Microbiologica

Volumn 29, Issue 1, 2006, Pages 1-10

  Fiorentini, Simona ^a   Marini, Elena ^a   Caracciolo, Sonia ^a   Caruso, Arnaldo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

AIDS pathogenesis; HIV 1 life cycle; Immune activation; Matrix protein p17

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MATRIX PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; VIRUS PROTEIN;

CHEMICAL STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; VIROLOGY; VIRUS ASSEMBLY; VIRUS REPLICATION;

GENE PRODUCTS, GAG; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; T-LYMPHOCYTES; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33645582928     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. ALCAMI, A. (2003). Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol, 3, 36-50.
2. ALCAMI, A., GHAZAL, P., AND YEWDELL, J.W. (2002). Viruses in control of the immune system. Workshop on molecular mechanisms of immune modulation: lessons from viruses. EMBO Rep, 3, 927-932.
3. BECKER, P.D., FIORENTINI, S., LINK, C., TOSTI, G., EBENSEN, T., CARUSO, A., AND GUZMÁN C.A. The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant. Vaccine, in press.
4. BELYAKOV, I.M., AND BERZOFSKY, J.A. (2004). Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20, 247-253.
5. BIRON, C.A., NGUYEN, K.B., PIEN, G.C., COUSENS, L.P., AND SALAZAR-MATHER, T.P. (1999). Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev of Immunol, 17, 189-220.
6. BUKRINSKAYA, A.G., GHORPADE, A., HEINZINGER, N.K., SMITHGALL, T.E., LEWIS R.E., AND STEVENSON, M. (1996). Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc Natl Acad Sci USA, 93, 367-371.
7. BUKRINSKY, M.I., HAGGERTY, S., DEMPSEY, M.P., SHAROVA, N., ADZHUBEL, A., SPITZ, L., LEWIS, P., GOLDFARB, D., EMERMAN, M., AND STEVENSON, M. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature, 365, 666-669.
8. CAMPBELL, S.M., CROWE, S.M., AND MAK, J. (2001). Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol, 22, 217-227.
9. CANNON, P.M., MATTHEWS, S., CLARK, N., BYLES, E.D., IOURIN, O., HOCKLEY, D.J., KINGSMAN, S.M., AND KINGSMAN, A.J. (1997). Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol, 71, 3474-3483.
10. CARUSO, A., POLLARA, P., FORESTI, I., BONFANTI, C., DE FRANCESCO, M., GELMI, M., AND TURANO, A. (1989). Interferon-gamma is associated with the surface of the human immunodeficiency virus and binds to the gag gene product p17. AIDS Res Hum Retroviruses, 5, 605-612.
11. CHAN, S.H., PERUSSIA, B., GUPTA, J.W., KOBAYASHY, M., POSPISIL, M., YOUNG, H.A., WOLF, S.W., YOUNG, D., CLARK, S.C., AND TRINCHIERI, G. (1991). Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med, 173, 869-879.
12. COFFIN, J.M., HUGHES, S.H., AND VARMUS, H.E. (1997). Retroviruses, Cold Spring Harbor Laboratory Press, Woodbury, NY
13. COSSON, P. (1996). Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J, 15, 5783-5788.
14. DE FRANCESCO, M.A., BARONIO, M., FIORENTINI, S., SIGNORINI, C., BONFANTI, C., POIESI, C., POPOVIC, M., GRASSI, M., GARRAFA, E., BOZZO, L., LEWIS, G.K., LICENZIATI, S., GALLO, R.C., AND CARUSO, A. (2002). HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. Proc Natl Acad Sci USA, 99, 9972-9977.
15. DE FRANCESCO, M.A., CARUSO, A., FALLACARA, F., CANARIS, A.D., DIMA, F., POIESI, C., LICENZIATI, S., CORULLI, M., MARTINELLI, F., FIORENTINI, S., AND TURANO, A. (1998). HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor. AIDS, 12, 245-252.
16. DONG, X., LI, H., DERDOWSKI, A., DING, L., BURNETT, A., CHEN, X., PETERS, T.R., DERMODY, T.S., WOODRUFF, E., WANG, J.J., AND SPEARMAN, P. (2005). AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell, 120, 663-674.
17. DORFMAN, T., MAMMANO, F., HASELTINE, W.A., AND GOTTLINGER, H.G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol, 68, 1689-1696.
18. DUPONT, S., SHAROVA, N., DEHORATIUS, C., VIRBASIUS, C.M., ZHU, X., BUKRINSKAYA, A.G., STEVENSON, M., AND GREEN, M.R. (1999). A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature, 402, 681-685.
19. EHRLICH, L.S., FONG, S., SCARLATA, S., ZYBARTH, G., AND CARTER, C. (1996). Partitioning of HIV-1 Gag and Gag-related proteins to membranes. Biochemistry, 35, 3933-3943.
20. FIORENTINI, S., BECKER, P.D., MARINI, E., MARCONI, P., AVOLIO, M., TOSTI, G., LINK, C., MANSERVIGI, R., GUZMAN, C.A. AND CARUSO, A. HIV-1 matrix protein p17 modulates in vivo preactivated murine T cell response and enhances the induction of systemic and mucosal immunity against intranasally coadministered antigens. Viral Immunol, in press
21. FIORENTINI, S., MARINI, E., BOZZO, L., TRAININI, L., SAADOUNE, L., AVOLIO, M., PONTILLO, A., BONFANTI, C., SARMIENTOS, P., AND CARUSO, A. (2004) Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH. Biopolymers, 76, 334-343.
22. FLAMMINIO, G., CARUSO, A., POIESI, C., BONFANTI, C., TERLENGHI, L., CANARIS, A.D., VARINACCI, C., MARTINELLI, F., GAROTTA, G., ALBERTINI, A., AND TURANO, A. (1995). Aspects of molecular interaction between HIV p17 and human gamma interferon. AIDS Res Hum Retroviruses, 11, 1441-1447.
23. FOUCHIER, R.A., MEYER B.E., SIMON J.H., FISCHER U., AND MALIM, M.H. (1997). HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J, 16, 4531-4539.
24. FOUNTOULAKIS, M., JURANVILLE, J.F., MARIS, A., OZMEN, L. AND GAROTTA, G. (1990). One interferon gamma receptor binds one interferon gamma dimer. J Biol Chem, 265, 19758-19767.
25. FRANKEL, A.D., AND YOUNG, J.A. (1998). HIV-1: fifteen proteins and an RNA. Annu Rev Biochem, 67, 1-25.
26. FREED, E.O., ENGLUND, G., AND MARTIN, M.A. (1995). Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol, 69, 3949-3954.
27. FREED, E.O., ENGLUND, G., MALDARELLI, F., AND MARTIN, M.A. (1997). Phosphorylation of residue 131 of HIV-1 matrix is not required for macrophage infection. Cell, 88, 171-173.
28. FREED, E.O., AND MARTIN, M.A. (1994). HIV-1 infection of nondividing cells. Nature, 369, 107-108.
29. FREED, E.O., AND MARTIN, M.A. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol, 70, 341-351.
30. FREED, E.O., ORENSTEIN, J.M., BUCKLER-WHITE, A.J., AND MARTIN, M.A. (1994). Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol, 68, 5311-5320.
31. GALLAY, P., SWINGLER, S., AIKEN, C., AND TRONO, D. (1995). C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell, 80, 379-388.
32. GALLAY, P., SWINGLER, S., SONG, J., BUSHMAN, F., AND TRONO, D. (1995). HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell, 83, 569-576.
33. GHEYSEN, D., JACOBS, E., DE FORESTA, F., THIRIART, C., FRANCOTTE, M., THINES, D., AND DE WILDE, M. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus infected insect cells. Cell, 59, 103-112.
34. GOTTLINGER, H.G., SODROSKI, J.G., AND HASELTINE, W.A. (1989). Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA, 86, 5781-5785.
35. HAFFAR, O.K., POPOV, S., DUBROVSKY, L., AGOSTINI, I., TANG, H., PUSHKARSKY, T., NADLER, S.G., AND BUKRINSKY, M. (2000). Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J Mol Biol, 299, 359-368.
36. HERMIDA-MATSUMOTO, L., AND RESH, M.D. (2000). Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol, 74, 8670-8679.
37. HILL, C.P., WORTHYLAKE, D., BANCROFT, D.P., CHRISTENSEN, A.M., AND SUNDQUIST, W.I. (1996). Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci USA, 93, 3099-3104.
38. HUNTER, E. (1994). Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol, 5, 71-83.
39. KAUSHIK, R., AND RATNER, L. (2004). Role of Human Immunodeficiency Virus Type 1 Matrix Phosphorylation in an Early Postentry Step of Virus Replication. J Virol, 78, 2319-2326.
40. KIERNAN, R.E., ONO, A., ENGLUND, G., AND FREED, E.O. (1998). Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J Virol, 72, 4116-4126.
41. KINTER, A.L., POLI, G., FOX, L., HARDY, E., FAUCI, A.S. (1995). HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J Immunol, 154, 2448-59.
42. MASSIAH, M.A., STARICH, M.R., PASCHALL, C., SUMMERS, M.F., CHRISTENSEN, A.M., AND SUNDQUIST, W.I. (1994). Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol, 244, 198-223.
43. MATTHEWS, S., BARLOW, P., BOYD, J., BARTON, G., RUSSELL, R., MILLS, H., CUNNINGHAM, M., MEYERS, N., BURNS, N., CLARK, N., KINGSMAN, S., KINGSMAN, A., AND CAMPBELL, I. (1994). Structural similarity between the p17 matrix protein of HIV-1 and interferon-gamma. Nature, 370, 666-668.
44. MCCABE, J.B., AND BERTHIAUME, L.G. (2001). N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae. Mol Biol Cell, 12, 3601-3617.
45. MILLER, M.D., FARNET, C.M., AND BUSHMAN, F.D. (1997). Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol, 71, 5382-5390.
46. NADLER, S.G., TRITSCHLER, D., HAFFAR, O.K., BLAKE, J., BRUCE, A.G., AND CLEAVELAND, J.S. (1997). Differential expression and sequence-specific interaction of karyopherin alpha with nuclear localization sequences. J Biol Chem, 272, 4310-4315.
47. NERMUT, M.V., HOCKLEY, D.J., JOWETT, J.B., JONES, I.M., GARREAU, M., AND THOMAS, D. (1994). Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus. Virology, 198, 288-296.
48. NGUYEN, D.G., BOOTH, A., GOULD, S.J., AND HILDRETH, J.E. (2003). Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem, 278, 52347-52354.
49. ONO, A., AND FREED, E.O. (2004). Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J Virol, 78, 1552-1563.
50. PELCHEN-MATTHEWS, A., KRAMER, B., AND MARSH, M. (2003). Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol, 162, 443-545.
51. POPOVIC, M., TENNER-RACZ, K., PELSER, C., STELLBRINK, H.J., VAN LUNZEN, J., LEWIS, G., KALYANARAMAN, V.S., GALLO, R.C., AND RACZ, P. (2005). Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA, 102, 14807-14812.
52. REIL, H., BUKOVSKY, A.A., GELDERBLOM, H.R., AND GOTTLINGER, H.G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J, 17, 2699-2708.
53. SCARLATA, S., EHRLICH, L.S., AND CARTER, C.A. (1998). Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. J Mol Biol, 277, 161-169.
54. SWANSTROM, R., AND WILLS, J.W. (1997). Synthesis, assembly, and processing of viral proteins. In "Retroviruses" (COFFIN, J.M., HUGHES, S.H., AND VARMUS, H.E. Eds.), 263-334. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
55. TAGAYA, Y., BAMFORD, R.N., DEFILIPPIS, A.P., AND WALDMANN, T.A. (1996). IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity, 4, 329-336.
56. TANG, C., LOELIGER, E., LUNCSFORD, P., KINDE, I., BECKETT, D., AND SUMMERS, M.F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci USA, 101, 517-522.
57. VICENZI, E., BISWAS, P., MENGOZZI, M., AND POLI, G. (1997). Role of pro-inflammatory cytokines and beta-chemokines in controlling HIV replication. J Leukoc Biol, 62, 34-40.
58. VITALE, M., CARUSO, A., DE FRANCESCO, M.A., RODELLA, L., BOZZO, L., GARRAFA, E., GRASSI, M., GOBBI, G., CACCHIOLI, A., AND FIORENTINI, S. (2003). HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines. Br J Haematol, 120, 337-343.
59. VOGT, V.M. (1997). Retroviral virions and genomes. In "Retroviruses" (COFFIN, J.M., HUGHES, S.H., AND VARMUS, H.E. Eds.), 27-70. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
60. VON SCHWEDLER, U., KORNBLUTH, R.S., AND TRONO, D. (1994). The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci USA, 91, 6992-6996.
61. WILLS, J.W., AND CRAVEN, R.C. (1991). Form, function, and use of retroviral Gag proteins. AIDS, 5, 639-654.
62. WU, Z., ALEXANDRATOS, J., ERICKSEN, B., LUBKOWSKI, J., GALLO, R.C., AND LU, W. (2004). Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci USA, 101, 11587-11592.
63. YU, X., YUAN X., MATSUDA, Z., LEE, T.H., AND ESSEX, M. (1992). The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol, 66, 4966-4971.
64. YUAN, X., YU, X., LEE, T.H., AND ESSEX, M. (1993). Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol, 67, 6387-6394.
65. ZHENG, Y.H., PLEMENITAS, A., LINNEMANN, T., FACKLER, O.T., AND PETERLIN, B.M. (2001). Nef increases infectivity of HIV via lipid rafts. Curr Biol, 11, 875-879.
66. ZHOU, W., PARENT, L.J., WILLS, J.W., AND RESH, M.D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol, 68, 2556-2569.
67. ZHOU, W., AND RESH, M.D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol, 70, 8540-8548.